Pivotal role for endothelial tetrahydrobiopterin in pulmonary hypertension.
BACKGROUND: Pulmonary hypertension is a fatal disease characterized by vasoconstriction and vascular remodeling. Loss of endothelial nitric oxide bioavailability is implicated in pulmonary hypertension pathogenesis. Recent evidence suggests that the cofactor tetrahydrobiopterin (BH4) is an importan...
Auteurs principaux: | Khoo, J, Zhao, L, Alp, N, Bendall, J, Nicoli, T, Rockett, K, Wilkins, MR, Channon, K |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
2005
|
Documents similaires
-
Tetrahydrobiopterin deficiency uncouples nitric oxide synthase and causes pulmonary hypertension
par: Khoo, J, et autres
Publié: (2004) -
Prevention of hypoxia-induced pulmonary hypertension and vascular remodelling by targeting endothelial tetrahydrobiopterin-dependent nitric oxide synthase regulation
par: Khoo, J, et autres
Publié: (2005) -
Tetrahydrobiopterin deficiency causes pulmonary hypertension: Effects on lung superoxide levels, hypoxic pulmonary vasoconstriction and vascular remodelling
par: Khoo, J, et autres
Publié: (2004) -
Endothelial tetrahydrobiopterin regulates eNOS coupling/uncoupling independent of vascular disease: Insights from targeted transgenic models
par: Bendall, J, et autres
Publié: (2004) -
Endothelial tetrahydrobiopterin (BH4) regulates eNOS coupling in vivo: Functional effects of BH4-eNOS stoichiometry in endothelial targeted transgenic mice
par: Bendall, J, et autres
Publié: (2005)